List of Excipients in API clopidogrel bisulphate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing clopidogrel bisulphate
Detailed excipient profiles for clopidogrel bisulphate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
clopidogrel bisulphate drug variants containing CELLULOSE, MICROCRYSTALLINE
clopidogrel bisulphate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
clopidogrel bisulphate drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | clopidogrel bisulphate | 53808-1031 |
| >Company | >Ingredient | >NDC |
clopidogrel bisulphate drug variants not containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Contract Pharmacy Services-PA | clopidogrel bisulphate | 67046-100 |
| NuCare PharmaceuticalsInc | clopidogrel bisulphate | 68071-4898 |
| REMEDYREPACK INC | clopidogrel bisulphate | 70518-0471 |
| REMEDYREPACK INC | clopidogrel bisulphate | 70518-1510 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
clopidogrel bisulphate drug variants containing FERRIC OXIDE RED
clopidogrel bisulphate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED CASTOR OIL
clopidogrel bisulphate drug variants containing HYDROGENATED CASTOR OIL
clopidogrel bisulphate drug variants not containing HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
clopidogrel bisulphate drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
clopidogrel bisulphate drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
clopidogrel bisulphate drug variants containing HYPROMELLOSE 2910
clopidogrel bisulphate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
clopidogrel bisulphate drug variants containing LACTOSE MONOHYDRATE
clopidogrel bisulphate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
clopidogrel bisulphate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Contract Pharmacy Services-PA | clopidogrel bisulphate | 67046-100 |
| NuCare PharmaceuticalsInc | clopidogrel bisulphate | 68071-4898 |
| REMEDYREPACK INC | clopidogrel bisulphate | 70518-0471 |
| REMEDYREPACK INC | clopidogrel bisulphate | 70518-1510 |
| >Company | >Ingredient | >NDC |
clopidogrel bisulphate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| State of Florida DOH Central Pharmacy | clopidogrel bisulphate | 53808-1031 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
clopidogrel bisulphate drug variants containing TITANIUM DIOXIDE
clopidogrel bisulphate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
clopidogrel bisulphate drug variants containing TRIACETIN
clopidogrel bisulphate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch